SkinBioTherapeutics finalizes agreement with Croda, eyes positive cash flow by FY25
SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, has finalized the commercial terms of its agreement with Croda plc following successful...
SkinBioTherapeutics has acquired Bio-Tech Solutions for £1.25 million
LONDON: SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announced the acquisition of the entire share capital of Bio-Tech Solutions Ltd...
SkinBioTherapeutics acquires Dermatonics Limited for £2.93 million
LONDON, UK: SkinBioTherapeutics plc (AIM: SBTX) has entered into an agreement to acquire the issued share capital of Dermatonics Limited, a specialist in innovative topical...